Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7393 p337
25 March 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Pharmacy drug misuse service guidance published

Cordelia Molloy/SPL

Supervised consumption services

Supervised consumption services required to meet needs of drug misusers

Guidance on commissioning pharmaceutical services for drug misusers in England has been published this week by the National Treatment Agency for Substance Misuse (NTA), the Royal Pharmaceutical Society and the Pharmaceutical Services Negotiating Committee.

In 2002, the Audit Commission’s report “Changing habits” identified pharmacists as an underused point of contact for the drug misusing population. To meet the needs of drug misusers, the NTA expects that 75 per cent of community pharmacies will need to be involved in providing supervised consumption and shared-care schemes and 25 per cent will need to be providing pharmacy needle exchange services.

The new document, “Best practice guidance for commissioners and providers of pharmaceutical services to drug users”, aims to assist commissioners and pharmacists in improving and increasing the level of provision of needle exchange schemes and dispensing, supervised consumption and shared-care services for this population.

It includes detailed sample service specifications and explains the new community pharmacy contract and how it is funded. There is also a section in the guidance that clarifies current and future roles for pharmacists in the drug misuse area. It describes different levels of expertise and roles in the various branches of the profession, including generalists, pharmacists with a special interest in drug misuse and consultants.

“Pharmacists who have completed part 2 [of the Royal College of General Practitioner’s certificate in the management of drug misuse in primary care] are an untapped resource with whom commissioners and drug action teams are encouraged to make contact,” the guidance states. “Such pharmacists are well suited for inclusion on shared care monitoring groups and strategic discussions with primary care trusts, primary care organisations and local pharmaceutical committees,” it adds.

David Pruce, director of practice and quality improvement at the Society, said: “This guidance will help pharmacists to promote their public health role in the area of drug misuse management. It provides advice for commissioners on services available from pharmacy and also includes background information on how pharmacy is funded. The guidance is important for drug users as it will help to ensure that any services commissioned are of the highest standard.”

Alastair Buxton, head of NHS services at the PSNC, said: “Community pharmacies have provided services to drug users for a great many years. This guidance helps to highlight this important role to service commissioners and draws together the key issues that need to be considered when a service is being implemented at a local level.”

The guidance is available to download from www.nta.nhs.uk, www.rpsgb.org and www.psnc.org.uk

Back to Top


©The Pharmaceutical Journal